awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48407672-9BAD214A-41F7-4E78-8E3B-D7D4EE3CA8F3
Q48407672-9BAD214A-41F7-4E78-8E3B-D7D4EE3CA8F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48407672-9BAD214A-41F7-4E78-8E3B-D7D4EE3CA8F3
An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease.
P2860
Q48407672-9BAD214A-41F7-4E78-8E3B-D7D4EE3CA8F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48407672-9BAD214A-41F7-4E78-8E3B-D7D4EE3CA8F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
20b44b3a4ae6ff760413e65d3ff273933ae152d5
P2860
Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex.